Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2002 Jul;78(921):385–392. doi: 10.1136/pmj.78.921.385

Methicillin resistant Staphylococcus aureus (MRSA) in the intensive care unit

A Haddadin 1, S Fappiano 1, P Lipsett 1
PMCID: PMC1742438  PMID: 12151652

Abstract

Methicillin resistant Staphylococcus aureus (MRSA) is a major nosocomial pathogen that causes severe morbidity and mortality worldwide. MRSA strains are endemic in many American and European hospitals and account for 29%–35% of all clinical isolates. Recent studies have documented the increased costs associated with MRSA infection, as well as the importance of colonisation pressure. Surveillance strategies have been proposed especially in high risk areas such as the intensive care unit. Pneumonia and bacteraemia account for the majority of MRSA serious clinical infections, but intra-abdominal infections, osteomyelitis, toxic shock syndrome, food poisoning, and deep tissue infections are also important clinical diseases. The traditional antibiotic therapy for MRSA is a glycopeptide, vancomycin. New antibiotics have been recently released that add to the armamentarium for therapy against MRSA and include linezolid, and quinupristin/dalfopristin, but cost, side effects, and resistance may limit their long term usefulness.

Full Text

The Full Text of this article is available as a PDF (160.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Archer G. L., Niemeyer D. M., Thanassi J. A., Pucci M. J. Dissemination among staphylococci of DNA sequences associated with methicillin resistance. Antimicrob Agents Chemother. 1994 Mar;38(3):447–454. doi: 10.1128/aac.38.3.447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Archibald L., Phillips L., Monnet D., McGowan J. E., Jr, Tenover F., Gaynes R. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis. 1997 Feb;24(2):211–215. doi: 10.1093/clinids/24.2.211. [DOI] [PubMed] [Google Scholar]
  3. Bailey R. J., Woolf I. L., Cullens H., Williams R. Metabolic inhibition of polymorphonuclear leucocytes in fulminant hepatic failure. Lancet. 1976 May 29;1(7970):1162–1163. doi: 10.1016/s0140-6736(76)91546-4. [DOI] [PubMed] [Google Scholar]
  4. Barakate M. S., Harris J. P., West R. H., Vickery A. M., Sharp C. A., Macleod C., Benn R. A. A prospective survey of current methicillin-resistant Staphylococcus aureus control measures. Aust N Z J Surg. 1999 Oct;69(10):712–716. doi: 10.1046/j.1440-1622.1999.01689.x. [DOI] [PubMed] [Google Scholar]
  5. Barakate M. S., Yang Y. X., Foo S. H., Vickery A. M., Sharp C. A., Fowler L. D., Harris J. P., West R. H., Macleod C., Benn R. A. An epidemiological survey of methicillin-resistant Staphylococcus aureus in a tertiary referral hospital. J Hosp Infect. 2000 Jan;44(1):19–26. doi: 10.1053/jhin.1999.0635. [DOI] [PubMed] [Google Scholar]
  6. Boyce J. M., Jackson M. M., Pugliese G., Batt M. D., Fleming D., Garner J. S., Hartstein A. I., Kauffman C. A., Simmons M., Weinstein R. Methicillin-resistant Staphylococcus aureus (MRSA): a briefing for acute care hospitals and nursing facilities. The AHA Technical Panel on Infections Within Hospitals. Infect Control Hosp Epidemiol. 1994 Feb;15(2):105–115. doi: 10.1086/646870. [DOI] [PubMed] [Google Scholar]
  7. Boyce J. M. MRSA patients: proven methods to treat colonization and infection. J Hosp Infect. 2001 Aug;48 (Suppl A):S9–14. doi: 10.1016/s0195-6701(01)90005-2. [DOI] [PubMed] [Google Scholar]
  8. Bures S., Fishbain J. T., Uyehara C. F., Parker J. M., Berg B. W. Computer keyboards and faucet handles as reservoirs of nosocomial pathogens in the intensive care unit. Am J Infect Control. 2000 Dec;28(6):465–471. doi: 10.1067/mic.2000.107267. [DOI] [PubMed] [Google Scholar]
  9. Chaix C., Durand-Zaleski I., Alberti C., Brun-Buisson C. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA. 1999 Nov 10;282(18):1745–1751. doi: 10.1001/jama.282.18.1745. [DOI] [PubMed] [Google Scholar]
  10. Chaix C., Durand-Zaleski I., Alberti C., Brun-Buisson C. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA. 1999 Nov 10;282(18):1745–1751. doi: 10.1001/jama.282.18.1745. [DOI] [PubMed] [Google Scholar]
  11. Chambers H. F. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev. 1997 Oct;10(4):781–791. doi: 10.1128/cmr.10.4.781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fierobe L., Decré D., Mùller C., Lucet J. C., Marmuse J. P., Mantz J., Desmonts J. M. Methicillin-resistant Staphylococcus aureus as a causative agent of postoperative intra-abdominal infection: relation to nasal colonization. Clin Infect Dis. 1999 Nov;29(5):1231–1238. doi: 10.1086/313454. [DOI] [PubMed] [Google Scholar]
  13. Fridkin S. K., Edwards J. R., Pichette S. C., Pryor E. R., McGowan J. E., Jr, Tenover F. C., Culver D. H., Gaynes R. P. Determinants of vancomycin use in adult intensive care units in 41 United States hospitals. Clin Infect Dis. 1999 May;28(5):1119–1125. doi: 10.1086/514752. [DOI] [PubMed] [Google Scholar]
  14. Galetto D. W., Johnston J. L., Archer G. L. Molecular epidemiology of trimethoprim resistance among coagulase-negative staphylococci. Antimicrob Agents Chemother. 1987 Nov;31(11):1683–1688. doi: 10.1128/aac.31.11.1683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Girou E., Pujade G., Legrand P., Cizeau F., Brun-Buisson C. Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clin Infect Dis. 1998 Sep;27(3):543–550. doi: 10.1086/514695. [DOI] [PubMed] [Google Scholar]
  16. Graziani A. L., Lawson L. A., Gibson G. A., Steinberg M. A., MacGregor R. R. Vancomycin concentrations in infected and noninfected human bone. Antimicrob Agents Chemother. 1988 Sep;32(9):1320–1322. doi: 10.1128/aac.32.9.1320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hartman B. J., Tomasz A. Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus. J Bacteriol. 1984 May;158(2):513–516. doi: 10.1128/jb.158.2.513-516.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hiramatsu K. Molecular evolution of MRSA. Microbiol Immunol. 1995;39(8):531–543. doi: 10.1111/j.1348-0421.1995.tb02239.x. [DOI] [PubMed] [Google Scholar]
  19. Jernigan J. A., Titus M. G., Gröschel D. H., Getchell-White S., Farr B. M. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am J Epidemiol. 1996 Mar 1;143(5):496–504. doi: 10.1093/oxfordjournals.aje.a008770. [DOI] [PubMed] [Google Scholar]
  20. John J. F., Jr, Grieshop T. J., Atkins L. M., Platt C. G. Widespread colonization of personnel at a Veterans Affairs medical center by methicillin-resistant, coagulase-negative Staphylococcus. Clin Infect Dis. 1993 Sep;17(3):380–388. doi: 10.1093/clinids/17.3.380. [DOI] [PubMed] [Google Scholar]
  21. Kaye K. S., Fraimow H. S., Abrutyn E. Pathogens resistant to antimicrobial agents. Epidemiology, molecular mechanisms, and clinical management. Infect Dis Clin North Am. 2000 Jun;14(2):293–319. doi: 10.1016/s0891-5520(05)70249-x. [DOI] [PubMed] [Google Scholar]
  22. Kloos W. E., Bannerman T. L. Update on clinical significance of coagulase-negative staphylococci. Clin Microbiol Rev. 1994 Jan;7(1):117–140. doi: 10.1128/cmr.7.1.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kuroda M., Ohta T., Uchiyama I., Baba T., Yuzawa H., Kobayashi I., Cui L., Oguchi A., Aoki K., Nagai Y. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet. 2001 Apr 21;357(9264):1225–1240. doi: 10.1016/s0140-6736(00)04403-2. [DOI] [PubMed] [Google Scholar]
  24. Langone J. J. Protein A of Staphylococcus aureus and related immunoglobulin receptors produced by streptococci and pneumonococci. Adv Immunol. 1982;32:157–252. [PubMed] [Google Scholar]
  25. Larson E. L., Early E., Cloonan P., Sugrue S., Parides M. An organizational climate intervention associated with increased handwashing and decreased nosocomial infections. Behav Med. 2000 Spring;26(1):14–22. doi: 10.1080/08964280009595749. [DOI] [PubMed] [Google Scholar]
  26. Liñares J. The VISA/GISA problem: therapeutic implications. Clin Microbiol Infect. 2001;7 (Suppl 4):8–15. doi: 10.1046/j.1469-0691.2001.00054.x. [DOI] [PubMed] [Google Scholar]
  27. Lowy F. D. Staphylococcus aureus infections. N Engl J Med. 1998 Aug 20;339(8):520–532. doi: 10.1056/NEJM199808203390806. [DOI] [PubMed] [Google Scholar]
  28. Lowy F. D. Staphylococcus aureus infections. N Engl J Med. 1998 Aug 20;339(8):520–532. doi: 10.1056/NEJM199808203390806. [DOI] [PubMed] [Google Scholar]
  29. Lundstrom T. S., Sobel J. D. Antibiotics for gram-positive bacterial infections. Vancomycin, teicoplanin, quinupristin/dalfopristin, and linezolid. Infect Dis Clin North Am. 2000 Jun;14(2):463–474. doi: 10.1016/s0891-5520(05)70258-0. [DOI] [PubMed] [Google Scholar]
  30. MILLIAN S. J., BALDWIN J. N., RHEINS M. S., WEISER H. H. Studies on the incidence of coagulase-positive staphylococci in a normal unconfined population. Am J Public Health Nations Health. 1960 Jun;50:791–798. doi: 10.2105/ajph.50.6_pt_1.791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Maranan M. C., Moreira B., Boyle-Vavra S., Daum R. S. Antimicrobial resistance in staphylococci. Epidemiology, molecular mechanisms, and clinical relevance. Infect Dis Clin North Am. 1997 Dec;11(4):813–849. doi: 10.1016/s0891-5520(05)70392-5. [DOI] [PubMed] [Google Scholar]
  32. Matzke G. R., Zhanel G. G., Guay D. R. Clinical pharmacokinetics of vancomycin. Clin Pharmacokinet. 1986 Jul-Aug;11(4):257–282. doi: 10.2165/00003088-198611040-00001. [DOI] [PubMed] [Google Scholar]
  33. Merrer J., Santoli F., Appéré de Vecchi C., Tran B., De Jonghe B., Outin H. "Colonization pressure" and risk of acquisition of methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol. 2000 Nov;21(11):718–723. doi: 10.1086/501721. [DOI] [PubMed] [Google Scholar]
  34. Merrer J., Santoli F., Appéré de Vecchi C., Tran B., De Jonghe B., Outin H. "Colonization pressure" and risk of acquisition of methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol. 2000 Nov;21(11):718–723. doi: 10.1086/501721. [DOI] [PubMed] [Google Scholar]
  35. Moreno F., Crisp C., Jorgensen J. H., Patterson J. E. Methicillin-resistant Staphylococcus aureus as a community organism. Clin Infect Dis. 1995 Nov;21(5):1308–1312. doi: 10.1093/clinids/21.5.1308. [DOI] [PubMed] [Google Scholar]
  36. Murakami K., Tomasz A. Involvement of multiple genetic determinants in high-level methicillin resistance in Staphylococcus aureus. J Bacteriol. 1989 Feb;171(2):874–879. doi: 10.1128/jb.171.2.874-879.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Neu H. C. The crisis in antibiotic resistance. Science. 1992 Aug 21;257(5073):1064–1073. doi: 10.1126/science.257.5073.1064. [DOI] [PubMed] [Google Scholar]
  38. Niemeyer D. M., Pucci M. J., Thanassi J. A., Sharma V. K., Archer G. L. Role of mecA transcriptional regulation in the phenotypic expression of methicillin resistance in Staphylococcus aureus. J Bacteriol. 1996 Sep;178(18):5464–5471. doi: 10.1128/jb.178.18.5464-5471.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Ogston A. Micrococcus Poisoning. J Anat Physiol. 1882 Oct;17(Pt 1):24–58. [PMC free article] [PubMed] [Google Scholar]
  40. Onorato M., Borucki M. J., Baillargeon G., Paar D. P., Freeman D. H., Cole C. P., Mayhall C. G. Risk factors for colonization or infection due to methicillin-resistant Staphylococcus aureus in HIV-positive patients: a retrospective case-control study. Infect Control Hosp Epidemiol. 1999 Jan;20(1):26–30. doi: 10.1086/501556. [DOI] [PubMed] [Google Scholar]
  41. Panlilio A. L., Culver D. H., Gaynes R. P., Banerjee S., Henderson T. S., Tolson J. S., Martone W. J. Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. Infect Control Hosp Epidemiol. 1992 Oct;13(10):582–586. doi: 10.1086/646432. [DOI] [PubMed] [Google Scholar]
  42. Panlilio A. L., Culver D. H., Gaynes R. P., Banerjee S., Henderson T. S., Tolson J. S., Martone W. J. Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. Infect Control Hosp Epidemiol. 1992 Oct;13(10):582–586. doi: 10.1086/646432. [DOI] [PubMed] [Google Scholar]
  43. Pujol M., Peña C., Pallares R., Ariza J., Ayats J., Dominguez M. A., Gudiol F. Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med. 1996 May;100(5):509–516. doi: 10.1016/s0002-9343(96)00014-9. [DOI] [PubMed] [Google Scholar]
  44. Pujol M., Peña C., Pallares R., Ariza J., Ayats J., Dominguez M. A., Gudiol F. Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med. 1996 May;100(5):509–516. doi: 10.1016/s0002-9343(96)00014-9. [DOI] [PubMed] [Google Scholar]
  45. Rello J., Torres A., Ricart M., Valles J., Gonzalez J., Artigas A., Rodriguez-Roisin R. Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med. 1994 Dec;150(6 Pt 1):1545–1549. doi: 10.1164/ajrccm.150.6.7952612. [DOI] [PubMed] [Google Scholar]
  46. Rutala W. A., Katz E. B., Sherertz R. J., Sarubbi F. A., Jr Environmental study of a methicillin-resistant Staphylococcus aureus epidemic in a burn unit. J Clin Microbiol. 1983 Sep;18(3):683–688. doi: 10.1128/jcm.18.3.683-688.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Selvey L. A., Whitby M., Johnson B. Nosocomial methicillin-resistant Staphylococcus aureus bacteremia: is it any worse than nosocomial methicillin-sensitive Staphylococcus aureus bacteremia? Infect Control Hosp Epidemiol. 2000 Oct;21(10):645–648. doi: 10.1086/501707. [DOI] [PubMed] [Google Scholar]
  48. Singh N., Paterson D. L., Chang F. Y., Gayowski T., Squier C., Wagener M. M., Marino I. R. Methicillin-resistant Staphylococcus aureus: the other emerging resistant gram-positive coccus among liver transplant recipients. Clin Infect Dis. 2000 Feb;30(2):322–327. doi: 10.1086/313658. [DOI] [PubMed] [Google Scholar]
  49. Sirvent J. M., Torres A., Vidaur L., Armengol J., de Batlle J., Bonet A. Tracheal colonisation within 24 h of intubation in patients with head trauma: risk factor for developing early-onset ventilator-associated pneumonia. Intensive Care Med. 2000 Sep;26(9):1369–1372. doi: 10.1007/s001340000611. [DOI] [PubMed] [Google Scholar]
  50. Soriano A., Martínez J. A., Mensa J., Marco F., Almela M., Moreno-Martínez A., Sánchez F., Muñoz I., Jiménez de Anta M. T., Soriano E. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. Clin Infect Dis. 2000 Feb;30(2):368–373. doi: 10.1086/313650. [DOI] [PubMed] [Google Scholar]
  51. Spratt B. G. Resistance to antibiotics mediated by target alterations. Science. 1994 Apr 15;264(5157):388–393. doi: 10.1126/science.8153626. [DOI] [PubMed] [Google Scholar]
  52. Thompson R. L., Cabezudo I., Wenzel R. P. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med. 1982 Sep;97(3):309–317. doi: 10.7326/0003-4819-97-3-309. [DOI] [PubMed] [Google Scholar]
  53. Tomasz A., Nachman S., Leaf H. Stable classes of phenotypic expression in methicillin-resistant clinical isolates of staphylococci. Antimicrob Agents Chemother. 1991 Jan;35(1):124–129. doi: 10.1128/aac.35.1.124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Tuazon C. U., Sheagren J. N. Increased rate of carriage of Staphylococcus aureus among narcotic addicts. J Infect Dis. 1974 Jun;129(6):725–727. doi: 10.1093/infdis/129.6.725. [DOI] [PubMed] [Google Scholar]
  55. Vincent J. L., Bihari D. J., Suter P. M., Bruining H. A., White J., Nicolas-Chanoin M. H., Wolff M., Spencer R. C., Hemmer M. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA. 1995 Aug 23;274(8):639–644. [PubMed] [Google Scholar]
  56. Vincent J. L., Bihari D. J., Suter P. M., Bruining H. A., White J., Nicolas-Chanoin M. H., Wolff M., Spencer R. C., Hemmer M. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA. 1995 Aug 23;274(8):639–644. [PubMed] [Google Scholar]
  57. Voss A., Milatovic D., Wallrauch-Schwarz C., Rosdahl V. T., Braveny I. Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis. 1994 Jan;13(1):50–55. doi: 10.1007/BF02026127. [DOI] [PubMed] [Google Scholar]
  58. Wadsworth S. J., Kim K. H., Satishchandran V., Axelrod P., Truant A. L., Suh B. Development of new antibiotic resistance in methicillin-resistant but not methicillin-susceptible Staphylococcus aureus. J Antimicrob Chemother. 1992 Dec;30(6):821–826. doi: 10.1093/jac/30.6.821. [DOI] [PubMed] [Google Scholar]
  59. Wagenvoort J. H., Sluijsmans W., Penders R. J. Better environmental survival of outbreak vs. sporadic MRSA isolates. J Hosp Infect. 2000 Jul;45(3):231–234. doi: 10.1053/jhin.2000.0757. [DOI] [PubMed] [Google Scholar]
  60. de Lencastre H., Couto I., Santos I., Melo-Cristino J., Torres-Pereira A., Tomasz A. Methicillin-resistant Staphylococcus aureus disease in a Portuguese hospital: characterization of clonal types by a combination of DNA typing methods. Eur J Clin Microbiol Infect Dis. 1994 Jan;13(1):64–73. doi: 10.1007/BF02026129. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES